Last month, the Food and Drug Administration (FDA) approved Voquenza Dual (vonoprazan fumarate + amoxicillin) and Triple Paks (vonoprazan fumarate + amoxicillin + clarithromycin) for the treatment of ...

H. pylori bacteria can disrupt your stomach's protective lining and cause peptic ulcers. You can treat H. pylori infections with antibiotics and medications that lower acid to prevent complications. H ...

Research has shown that the formation of stomach ulcers is associated with colonization of the stomach with Helicobacter pylori bacteria. A significant body of evidence exists demonstrating the link ...

European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission We conducted a retrospective cohort ...

A breakthrough in identifying how a common ulcer-causing bacteria survives in the human stomach will lead to new medications and possible eradication, according to a WA Nobel Prize-winning scientist.

Helicobacter pylori (H. pylori) is a common type of bacteria that infects the stomach lining and can lead to various gastrointestinal diseases such as gastritis, stomach ulcers, and cancer. The ...

H. pylori is a bacteria that can damage the stomach’s protective lining. Untreated, an H.pylori infection may lead to complications. H. pylori is a common type of bacteria that grows in the digestive ...

Some natural treatments, including probiotics and broccoli sprouts, may help reduce the number of H. pylori bacteria in your stomach. However, eradicating the bacteria typically requires antibiotics.

The global helicobacter pylori infections treatment market is set for significant expansion, with a market value projected to reach USD 638.3 million in 2023. This robust growth trajectory is expected ...

Phil Sutton receives funding from the National Health and Medical Research Council and the National Foundation for Medical Research and Innovation. In 1982, two Australians – Robin Warren and Barry ...